• Home
  • Search Results
  • Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.

Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.

Molecular neurobiology (2019-02-03)
Elisa Meneghetti, Lisa Gasperini, Tommaso Virgilio, Fabio Moda, Fabrizio Tagliavini, Federico Benetti, Giuseppe Legname

Prion diseases are fatal neurodegenerative disorders characterized by the cellular prion protein (PrPC) conversion into a misfolded and infectious isoform termed prion or PrPSc. The neuropathological mechanism underlying prion toxicity is still unclear, and the debate on prion protein gain- or loss-of-function is still open. PrPC participates to a plethora of physiological mechanisms. For instance, PrPC and copper cooperatively modulate N-methyl-D-aspartate receptor (NMDAR) activity by mediating S-nitrosylation, an inhibitory post-translational modification, hence protecting neurons from excitotoxicity. Here, NMDAR S-nitrosylation levels were biochemically investigated at pre- and post-symptomatic stages of mice intracerebrally inoculated with RML, 139A, and ME7 prion strains. Neuropathological aspects of prion disease were studied by histological analysis and proteinase K digestion. We report that hippocampal NMDAR S-nitrosylation is greatly reduced in all three prion strain infections in both pre-symptomatic and terminal stages of mouse disease. Indeed, we show that NMDAR S-nitrosylation dysregulation affecting prion-inoculated animals precedes the appearance of clinical signs of disease and visible neuropathological changes, such as PrPSc accumulation and deposition. The pre-symptomatic reduction of NMDAR S-nitrosylation in prion-infected mice may be a possible cause of neuronal death in prion pathology, and it might contribute to the pathology progression opening new therapeutic strategies against prion disorders.

Product Number
Product Description

HEPES, ≥99.5% (titration)
Sodium dodecyl sulfate, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Ethylenediaminetetraacetic acid, anhydrous, crystalline, BioReagent, suitable for cell culture
(+)-Sodium L-ascorbate, powder, BioReagent, suitable for cell culture
Neocuproine, ≥98%
Monoclonal Anti-β-Actin−Peroxidase antibody produced in mouse, clone AC-15, purified from hybridoma cell culture
CHAPS hydrate, BioReagent, suitable for electrophoresis, ≥98% (HPLC)
S-Methyl methanethiosulfonate, purum, ≥98.0% (GC)
Anti-Glutamate Receptor NMDAR1 (NR1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution